Clinical Trials Sponsored by Cepheid

Total 23 results

Cepheid

Completed

Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)

Leukemia, Myelogenous, Chronic

United States
Cepheid

Completed

Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer

Bladder Cancer

United States, Canada, Netherlands
Cepheid

Completed

Clinical Evaluation of the Xpert® HIV-1 VL

Human Immunodeficiency Virus
Emory University
Cepheid

Terminated

FMT for MDRO Colonization After Infection in Renal Transplant Recipients (PREMIX)

Infection Due to Resistant Organism

United States
Mansoura University
Cepheid

Completed

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

Bladder Cancer

Egypt
Carmel Medical Center
Cepheid

Completed

The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis

GBS

Israel
George Washington University
Cepheid

Completed

Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED

Reproductive Tract Infections

United States
Institut Claudius Regaud
Cepheid

Unknown

Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC (CEPHEID)

Non Muscle Invasive Bladder Cancer | Treatment by BCG

France
Henry Ford Health System
Cepheid

Completed

Emergency Department, Rapid Assessment for Sexually Transmitted Infection (ED-RASTI)

Infection

United States
Cepheid
Axonal-Biostatem; Stève Consultants

Completed

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) (ANTICIPATE X)

Non-muscle-invasive Bladder Cancer

United Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
Jørgen Bjerggaard Jensen
Cepheid

Active, not recruiting

Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor (SEALS Xpert)

Non-muscle Invasive Bladder Cancer | Urinary Biomarker

Denmark
Boston Medical Center
Cepheid; Optimer Pharmaceuticals LLC

Completed

Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease | Clostridium Difficile

United States
Cephea Valve Technologies

Completed

Cephea Transseptal Mitral Valve System FIH

Mitral Regurgitation

Australia
Clinique Beau Soleil
Cepheid; Team Languedoc Mutualité / Nouvelles technologies

Completed

Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test. (Xpert Bladder)

Non-Invasive Bladder Urothelial Carcinoma | Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade | Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade

France
Cepheid
Centers for Disease Control and Prevention; AIDS Clinical Trials Group

Completed

Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects

Tuberculosis

United States
Michael E. DeBakey VA Medical Center
Baylor College of Medicine; Cepheid

Completed

Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections

Bacteremia | Staphylococcus Aureus | Staphylococcal Skin Infections

United States
Centre hospitalier de l'Université de Montréal...
Gilead Sciences; Cepheid

Completed

Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs

Hepatitis C | Intravenous Drug Users

Canada
Centre Hospitalier Universitaire Saint Pierre
AbbVie; Gilead Sciences; Cepheid; Réseau Hépatite C Bruxelles

Completed

HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels

Hepatitis C, Chronic

Belgium
Jørgen Bjerggaard Jensen
Laborie Medical Technologies Inc.; Cepheid; Vingmed Danmark A/S; OneMed A/S

Enrolling by invitation

GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit

Urinary Bladder Neoplasms

Denmark, Greenland
ANRS, Emerging Infectious Diseases
Programme PAC-CI; Centre Population et Développement (CEPED/IRD)

Recruiting

Feasibility and Effectiveness of a Pilot Program of Physical Activity to Improve HIV Related Functional Limitations and Disability in Adults Aged 40 and Older From Côte d'Ivoire (VIRAGE+)

HIV Infections

Côte D'Ivoire
Foundation for Innovative New Diagnostics, Switzerland
University of Witwatersrand, South Africa; PD Hinduja Hospital and Medical... and other collaborators

Completed

Xpert MTB/XDR Clinical Evaluation Trial

Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant

Moldova, Republic of
Michael Hoelscher
Karolinska Institutet; University of Stellenbosch; University of Cape Town Lung... and other collaborators

Completed

Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB) (RaPaed)

Tuberculosis | Diagnoses Disease

India, Mozambique, Tanzania, Malawi, South Africa
ANRS, Emerging Infectious Diseases
Aix Marseille Université; Fondation de France; Université du Québec a Montréal; Centre Population et Développement (CEPED), Paris, France and other collaborators

Unknown

ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali

HIV/AIDS | HIV Seropositivity | Empowerment | Disclosure

Mali

Clinical Trials Sponsored by Cepheid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations